Inga feuilleei - Pacay, Ice Cream Bean: Medicinal Uses, Recipes and Formulations

Inga feuilleei, commonly known as Pacay, Ice Cream Bean, or Guama, is a fast-growing leguminous tree of the Fabaceae family whose medicinal and nutritional value is centered on its polyphenol-rich fractions and their antioxidant, anti-inflammatory, and antimicrobial potential. It is a species native to Peru, cultivated since at least 4500 B.C. and spread through the Inca Empire, valued for its sweet edible pulp and its traditional use in folk medicine for inflammatory conditions, digestive complaints, and respiratory congestion . The leaves, in particular, are exceptionally rich in polyphenols, primarily flavonoids, and have been used traditionally as an anti-inflammatory, nasal decongestant, antidiarrheal, and for arthritis, rheumatism, and digestive problems . Beyond its traditional applications, pharmacological exploration has identified significant antioxidant and anticarcinogenic potential in the species, with flavonoids such as quercetin, coumaric acid, and isoflavones identified as the responsible compounds . This comprehensive action on oxidative stress, inflammation, and microbial pathways makes it a valuable phytomedicine for conditions characterized by chronic inflammation and oxidative damage, while its nutritional profile positions it as a functional food ingredient.

A Critical Note on the Evidence Base

A critical caveat must preface this monograph. The scientific literature specifically evaluating the medicinal properties of Inga feuilleei is limited and preliminary. The most substantive pharmacological exploration is a 2024 study that included I. feuilleei alongside two other Andean Fabaceae species, finding that it exhibited antioxidant capacity and phenolic content second only to tara among the three, with quercetin, coumaric acid, and isoflavones identified as the active compounds . No human clinical trials on I. feuilleei for any medicinal indication have been identified. The traditional uses documented are ethnobotanical reports rather than clinically validated indications. This monograph therefore presents the available evidence with appropriate caveats, distinguishing between documented traditional use, preclinical phytochemical findings, and the substantial gaps requiring further research.

Medicinal Uses: Summary of Primary and Secondary Actions

Primary Actions

1. Antioxidant and Anti-inflammatory

Inga feuilleei is a polyphenol-rich botanical with significant antioxidant potential. The 2024 Andean Fabaceae study identified antioxidant capacity in I. feuilleei, attributed to flavonoids including quercetin, coumaric acid, and isoflavones . The leaves are particularly rich in polyphenols, and traditional use explicitly includes anti-inflammatory applications for arthritis, rheumatism, and digestive problems . A separate study on the methanolic extract of I. feuilleei leaves quantified total polyphenol content at 33.25 milligrams of catechin equivalents per gram of dry sample and antioxidant capacity at 141.79 millimolar Trolox equivalents per gram, concluding that polyphenols are components that contribute an important percentage of the antioxidant capacity . The fruit fractions also demonstrate high polyphenol content, with the peel reaching 1843 milligrams of gallic acid equivalents per 100 grams, the highest among the fractions studied . This antioxidant foundation supports the traditional use for inflammatory conditions and positions the plant as a source of functional ingredients.

2. Antimicrobial Potential

The Andean Fabaceae exploration included antimicrobial properties among the interventions evaluated for I. feuilleei . While the specific antimicrobial results for I. feuilleei are not detailed in the available summaries, the inclusion of this species in a study explicitly designed to explore antimicrobial potential indicates that activity was investigated and may have been observed. The polyphenol and flavonoid content provides a plausible mechanistic basis, as these compound classes are well-documented antimicrobial agents. However, without specific minimum inhibitory concentration data or pathogen-specific results, this action must be classified as preliminary and requiring confirmation.

3. Anticarcinogenic Potential

The same 2024 study evaluated anticarcinogenic properties across the three Andean species . The identification of flavonoids including quercetin and isoflavones as responsible for the pharmacological potential provides a mechanistic rationale, as these compounds have documented anticancer activities in other contexts. However, the specific results for I. feuilleei on cancer cell lines are not detailed in the available summaries. This action is therefore classified as emerging and preliminary, warranting further investigation before any therapeutic application can be considered.

4. Nutritional and Functional Food Applications

The edible pulp of the pacay fruit is sweet and cottony, consumed fresh as a snack . A comprehensive nutritional analysis of Peruvian pacay varieties found that the edible part contains high amounts of carbohydrates (84 to 87 percent), the seeds are rich in protein (18 to 21 percent), and the peels are rich in fiber (approximately 34 percent) . Amylopectin was the majority starch fraction (86 percent) in the seeds. All fractions stood out for high total polyphenol content, with hydroxycinnamic acids (40 to 136 milligrams ferulic acid equivalents per 100 grams) higher than flavonols (18 to 50 milligrams gallic acid equivalents per 100 grams), both present in higher amounts in the seed fraction . These findings support the revalorization of pacay as a functional ingredient for food formulation, particularly for its polyphenol and fiber content.

5. Traditional Anti-inflammatory and Digestive Applications

The leaves of I. feuilleei have been used in popular medicine as an anti-inflammatory, nasal decongestant, antidiarrheal, and against arthritis, rheumatism, and digestive problems . This traditional use profile aligns with the polyphenol content and antioxidant capacity of the leaves. The anti-inflammatory and antidiarrheal applications are consistent with the flavonoid profile, as quercetin and related compounds have documented activity in these areas. The nasal decongestant use is less directly explained by the identified compounds, suggesting that other constituents or mechanisms may be involved. These traditional uses provide ethnomedicinal validation for further investigation but have not been confirmed in controlled clinical studies.

Secondary Actions and Nutritional Profile

1. Fiber-Rich Fractions for Digestive Health

The peel fraction of the pacay fruit is notably rich in fiber, at approximately 34 percent . Dietary fiber supports bowel regularity, feeds beneficial gut bacteria, and contributes to glycemic control. The traditional use of the leaves for digestive problems may be partly attributable to the fiber content, although the leaves and peel are distinct fractions. The peel, typically discarded during consumption, represents a potentially valuable source of functional fiber for food and supplement applications .

2. Protein-Rich Seeds

The seeds of I. feuilleei contain 18 to 21 percent protein, making them a potentially valuable plant protein source . The seeds also contain trypsin inhibitors, which offer protection to the fruit against insect damage and have biotechnological implications for pest resistance . While trypsin inhibitors can reduce protein digestibility if consumed raw, proper cooking or processing would be expected to mitigate this effect. The protein content of the seeds positions them as a nutritional resource, though they are typically discarded along with the pod during fresh consumption .

Critical Safety Warning: Toxicity and Dosage

Inga feuilleei is generally regarded as non-toxic, with no known hazards documented in the Useful Tropical Plants database . The fruit is widely consumed fresh for its sweet pulp, and the species has a long history of use as food and fodder . The Plant Pono risk assessment lists "Non-toxic" and "Prized for the sweet edible aril" among its low-risk traits .

However, several critical safety considerations must be noted. The seeds contain trypsin inhibitors, which can interfere with protein digestion if consumed raw or inadequately processed . Traditional consumption typically involves discarding the seeds and consuming only the pulp, or cooking the seeds where they are used. Any preparation involving the seeds should include thorough cooking to deactivate these compounds. The long-term safety of concentrated leaf or peel extracts for medicinal use has not been established. No toxicological studies, acute or chronic, have been identified for I. feuilleei extracts.

The use of I. feuilleei during pregnancy and lactation has not been studied, and therapeutic doses of concentrated extracts should be avoided during these periods without professional guidance. Individuals with known allergies to legumes or Fabaceae plants should exercise caution, as cross-reactivity is possible. The plant's potential for spread as an invasive species in tropical climates, while not a direct human safety concern, is noted in the Plant Pono assessment, which recommends caution to prevent negative ecosystem impacts in places like Hawaii .

Medicinal Parts

The leaves, fruit pulp, peel, and seeds are the primary parts with documented or potential applications.

Leaves: The leaves are the primary medicinal part in traditional use, employed as an anti-inflammatory, nasal decongestant, antidiarrheal, and for arthritis, rheumatism, and digestive problems . The leaves are particularly rich in polyphenols, mainly flavonoids, and have demonstrated antioxidant capacity in the methanolic extract . The leaves are the most extensively studied fraction for medicinal potential.

Fruit Pulp (Sarcotesta): The edible white, cottony pulp surrounding the seeds is the primary food use. It is sweet and consumed fresh . The edible part contains high carbohydrates (84 to 87 percent) and contributes to the nutritional value of the fruit . While not the primary medicinal fraction in traditional use, the pulp's consumption contributes to overall polyphenol intake.

Peel (Mesocarp/Shell): The peel is typically discarded during consumption but is the richest fraction in total polyphenols (1843 milligrams gallic acid equivalents per 100 grams) and fiber (approximately 34 percent) . This positions the peel as a potentially valuable source of functional ingredients, though it is not traditionally used medicinally in the documented ethnobotanical record.

Seeds: The seeds are rich in protein (18 to 21 percent) and contain hydroxycinnamic acids and flavonols at higher concentrations than other fractions . They also contain trypsin inhibitors . The seeds are typically discarded during fresh consumption but represent a nutritional resource if properly processed.

Phytochemistry

The pharmacological and nutritional activity of Inga feuilleei is driven by its polyphenol profile, fiber, and protein content.

1. Flavonoids (Leaves, Fruit Fractions)

This is the signature chemical class responsible for the antioxidant, anti-inflammatory, and anticarcinogenic potential. The 2024 Andean Fabaceae study identified quercetin, coumaric acid, and isoflavones as the flavonoids responsible for the observed antioxidant and pharmacological potential in I. feuilleei . The leaves are particularly rich in polyphenols, mainly flavonoids . These compounds are well-documented antioxidants and anti-inflammatory agents, providing a mechanistic basis for the traditional uses of the leaves.

2. Phenolic Acids (Fruit Fractions)

Hydroxycinnamic acids were present at concentrations of 40 to 136 milligrams ferulic acid equivalents per 100 grams across the fruit fractions, higher than flavonols, and were present in higher amounts in the seed fraction . These phenolic acids contribute to the antioxidant capacity and are known to possess anti-inflammatory and antimicrobial properties. The peel's high total polyphenol content (1843 milligrams gallic acid equivalents per 100 grams) suggests it is a concentrated source of these compounds .

3. Fiber (Peel)

The peel contains approximately 34 percent fiber . This fiber contributes to digestive health, supports the gut microbiome, and may modulate glycemic response when consumed with meals. The fiber content, combined with polyphenols, makes the peel a candidate functional ingredient for metabolic and digestive health applications.

4. Protein and Trypsin Inhibitors (Seeds)

The seeds contain 18 to 21 percent protein and trypsin inhibitors . While the protein is nutritionally valuable, the trypsin inhibitors require inactivation through cooking. These inhibitors are of biotechnological interest for pest resistance but are not therapeutically beneficial in the raw seed.

Traditional and Ethnobotanical Uses

1. Anti-inflammatory and Antirheumatic Applications

Formulation: Leaf decoction or infusion.

Preparation and Use: The leaves are used in popular medicine as an anti-inflammatory and against arthritis and rheumatism . A traditional preparation would involve preparing a decoction or infusion of the dried or fresh leaves. The specific preparation method and dosage are not detailed in the available ethnobotanical literature, but typical herbal preparations involve steeping or simmering the leaves in water and consuming the liquid.

Evidence Basis: The traditional use is documented in ethnobotanical reports, and the polyphenol content of the leaves provides a plausible mechanistic basis . However, no clinical or preclinical studies specifically evaluating the anti-inflammatory efficacy of I. feuilleei leaf preparations in animal models or humans have been identified. This use is classified as traditional with preliminary phytochemical support.

2. Digestive Complaints and Antidiarrheal Use

Formulation: Leaf preparation.

Preparation and Use: The leaves are traditionally used for digestive problems and as an antidiarrheal . The preparation would likely be a leaf infusion or decoction consumed orally. The fiber content of the plant fractions may contribute to the digestive effects, although the leaves are not the primary fiber-rich fraction.

Evidence Basis: Documented traditional use only. No specific pharmacological studies on the antidiarrheal activity of I. feuilleei have been identified.

3. Nasal Decongestant

Formulation: Leaf preparation, method unspecified.

Preparation and Use: The leaves are used traditionally as a nasal decongestant . The specific method of preparation and administration (e.g., inhalation, oral consumption) is not detailed in the available source.

Evidence Basis: Documented traditional use only. The mechanism is not explained by the identified flavonoid constituents, suggesting that other compounds or volatile components may be involved. This use requires further investigation.

4. Nutritional Consumption of Fruit

Formulation: Fresh fruit pulp.

Preparation and Use: The sweet, cottony white pulp surrounding the seeds is consumed fresh as a snack . The pod is opened, and the pulp is eaten directly from around the seeds. This is the primary food use of the plant and has a history spanning millennia in the Andes .

Evidence Basis: The nutritional composition has been characterized, confirming the carbohydrate content and polyphenol presence . This is a well-documented food use rather than a medicinal preparation per se, but the polyphenol content contributes to dietary antioxidant intake.

Clinical Significance and Evidence Summary

1. Evidence Hierarchy by Activity

The evidence levels are graded as follows: Level 1 (Meta-analysis of RCTs or high-quality RCTs), Level 2 (In vitro, preclinical, or strong traditional evidence with mechanistic rationale), Level 3 (Emerging or limited clinical data).

Antioxidant: Level 2. In vitro evidence from multiple studies demonstrating antioxidant capacity of leaf extracts and fruit fractions, with identification of responsible flavonoids . The mechanism is well-supported, but no in vivo or clinical studies have been identified.

Anti-inflammatory: Level 3. Documented traditional use with a plausible mechanistic basis from polyphenol content, but no specific preclinical inflammation studies or clinical trials .

Antimicrobial and Anticarcinogenic: Level 3. The 2024 Andean Fabaceae study included these interventions in its exploration, but specific results for I. feuilleei are not detailed in available summaries . These are emerging areas requiring dedicated investigation.

Nutritional and Functional Food: Level 2. Comprehensive nutritional characterization of fruit fractions has been published, providing a strong basis for functional food applications .

2. Research Gaps and Limitations

The evidence base for Inga feuilleei is in its infancy. The most significant limitation is the complete absence of human clinical trials for any medicinal indication. The traditional uses for inflammation, digestion, and respiratory congestion are ethnobotanical reports that have not been subjected to controlled experimental validation. The 2024 Andean Fabaceae study is the most comprehensive pharmacological exploration, but the specific results for I. feuilleei on antimicrobial and anticarcinogenic endpoints are not fully detailed in the available summaries . The antioxidant and phytochemical studies provide a foundation, but they are in vitro and do not establish in vivo efficacy.

Priority research needs include: dedicated in vivo studies on the anti-inflammatory activity of leaf extracts in animal models of arthritis and inflammation; antimicrobial testing against specific pathogens with minimum inhibitory concentration determination; cytotoxicity studies against cancer cell lines with selectivity assessment; and acute and sub-chronic toxicological studies to establish safety parameters. The nutritional and functional food potential of the peel and seed fractions also warrants investigation through food science and human intervention studies.

Drug Interactions

No specific drug interaction studies have been conducted on Inga feuilleei. Based on its phytochemical profile, the following theoretical considerations warrant monitoring.

Potential Additive Antioxidant Effects: The high polyphenol content of leaf and fruit extracts may produce additive effects with other antioxidant supplements or medications. This is unlikely to be harmful but should be noted.

Potential Additive Anti-inflammatory Effects: If the leaf preparations demonstrate anti-inflammatory activity in vivo, co-administration with non-steroidal anti-inflammatory drugs or other anti-inflammatory medications could produce additive effects.

Fiber-Related Interactions: The fiber-rich peel fraction, if consumed in concentrated form, may reduce the absorption of minerals or medications taken concurrently. Medications should be taken at least two hours apart from high-fiber preparations.

Final Summary of Contraindications and Precautions

Absolute Contraindications:

· Known allergy to Inga feuilleei or other plants in the Fabaceae family.

Use with Caution:

· Pregnancy and breastfeeding: therapeutic doses of concentrated leaf or peel extracts should be avoided due to lack of safety data.

· Consumption of raw seeds: trypsin inhibitors require inactivation through cooking .

· Individuals taking medications with a narrow therapeutic index: high-fiber preparations may affect absorption.

· Individuals with known legume allergies: cross-reactivity is possible.

Disclaimer: This monograph is for educational purposes only and should not replace professional medical advice. Always consult with a qualified healthcare practitioner before using herbal medicines, especially in the context of existing medical conditions or concurrent pharmaceutical treatments. The evidence for Inga feuilleei as a medicinal agent is preliminary and largely derived from in vitro phytochemical studies and ethnobotanical reports. No human clinical trials have established efficacy or safety for any medicinal indication. Traditional uses should not be assumed to be clinically validated, and the plant should not replace standard medical care for inflammatory, digestive, or respiratory conditions.